Highest quality from a single source

From cultivation to the pharmacy

Wholesale

DEMECAN works with producers of medical cannabis worldwide to ensure a reliable and continuous supply of medical cannabis for patients in Germany.

Cultivation

DEMECAN will begin cultivating medical cannabis in Germany in its production facility near Dresden in 2020.

Research

Medical cannabis is now available for prescription in Germany. Nevertheless, there are still many open questions about the plant and its medical effects.

The world is changing

New challenges require innovation and creativity to arrive at new solutions.

Wholesale

We cooperate with international producers of medical cannabis to ensure a reliable and continuous supply of medical cannabis for patients in Germany and Europe.

Pharmacies can order directly in our shop. Please register to view more detailed information.

Our Suppliers

Bedrocan varieties are currently available. Our wholesale holds AmRadV licenses from the German cannabis agency for all Bedrocan varieties.

Invictus will start supplying DEMECAN by the end of 2020.

Invictus MD

Little Green Pharma will start supplying DEMECAN in the second half of 2020.

We are a member of VCA

Our licenses

DEMECAN holds all required licenses for import and wholesale of medical cannabis in Germany.

Cultivation

DEMECAN Quality

DEMECAN will start cultivating medical cannabis in Germany in its facilities close to Dresden in 2020. DEMECAN cannabis is produced in accordance with GACP and EU-GMP regulations ensuring the highest pharmaceutical quality.

Controlled indoor production

Our cannabis plants are grown indoor under complete climate control – from tissue culture cells in the laboratory to harvest. We control the lighting and temperature conditions ideally and dynamically to the needs of our plants in order to ensure continuous production and constant pharmaceutical quality. With high performance filtration and airlock systems, we prevent pests and spores from entering our production facility. This allows us to produce clean and natural cannabis – without pesticides and irradiation. We use pure and sterilized water from a pharmaceutical reverse osmosis system, which enables us to tightly control all nutrients that our plants need in order to grow ideally.

Assured quality standards

Our entire production is compliant with two essential phytopharmaceutical quality standards: GACP and EU-GMP.

GACP (Good Agricultural and Collection Practice) is a set of guidelines, which describes how plants intended for medical use should be cultivated. DEMECAN places the highest standards on purity, hygiene and processing quality of all cannabis plants.

EU-GMP (Good Manufacturing Practice) is also a set of guidelines, which regulates exactly how pharmaceuticals are to be manufactured in Germany and the EU. All standard operating procedures and quality documentations, test results and shipments to pharmacies are subject to precise guidelines and recurring controls to ensure patient safety.

Your health is most important to us!

Research on medical cannabis

Research and Development

Cannabis has been used as a medicinal plant for a long time. However, research on effects of environmental conditions on the medical effectiveness of different strains is still at an early stage. DEMECAN supports cannabis research and is a member of the International Research Network Cannabis-Net at the University of Hohenheim.

Medical use

Physicians can prescribe medical cannabis in Germany. Alongside with the prescriptions an accompanying study is coordinated by the Federal Institute for Drugs and Medical Devices (BfArM).

Dosage forms

Cannabis flowers can be administered either as tea or vaporized. Oil or ethanol based extracts can be taken orally in the form of drops.

Alternative therapy options

Increasing scientific evidence continues to show powerful medicinal properties in a wide variety of ancient botanicals and is ushering in a new culteral acceptance for their main stream usage. This trend is paving the way for cannabis as an established and preferred medicinal option for patients. We support this path and promote evidence-based modern therapies with a focus on patient health.